Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.99 USD | +1.32% | +5.38% | -16.05% |
Sales 2024 | 1,60400Cr 1.02TCr 85TCr | Sales 2025 * | 1,67800Cr 1.07TCr 89TCr | Capitalization | 2,80700Cr 1.79TCr 1,48400Cr |
---|---|---|---|---|---|
Net income 2024 | 1.7TCr 11Cr 901.41Cr | Net income 2025 * | 8.8TCr 56Cr 4.65TCr | EV / Sales 2024 | 1.84 x |
Net Debt 2024 * | 50TCr 320.6Cr 27TCr | Net Debt 2025 * | 51TCr 326.05Cr 27TCr | EV / Sales 2025 * | 1.98 x |
P/E ratio 2024 |
173
x | P/E ratio 2025 * |
32
x | Employees | 14,484 |
Yield 2024 |
4.26% | Yield 2025 * |
4.79% | Free-Float | 98.83% |
Latest transcript on Astellas Pharma Inc.
1 day | +1.32% | ||
1 week | +5.38% | ||
Current month | +4.61% | ||
1 month | +4.72% | ||
3 months | -9.10% | ||
6 months | -17.85% | ||
Current year | -16.05% |
Managers | Title | Age | Since |
---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 61 | 01/86/01 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 52 | 01/11 |
Kenji Yasukawa
CHM | Chairman | 63 | 01/86/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takashi Tanaka
BRD | Director/Board Member | 67 | 01/21/01 |
Mamoru Sekiyama
BRD | Director/Board Member | 74 | 01/17/01 |
Naoki Okamura
CEO | Chief Executive Officer | 61 | 01/86/01 |
Date | Price | Change | Volume |
---|---|---|---|
24/24/24 | 9.99 | +1.32% | 410,404 |
23/24/23 | 9.86 | +1.54% | 297,250 |
22/24/22 | 9.71 | +1.25% | 221,086 |
21/24/21 | 9.59 | -0.52% | 178,073 |
20/24/20 | 9.64 | +1.69% | 181,751 |
Delayed Quote OTC Markets, May 25, 2024 at 01:29 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 73TCr | |
+33.05% | 60TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+16.00% | 24TCr | |
+8.09% | 20TCr | |
-5.77% | 20TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- 4503 Stock
- ALPMY Stock